AstraZeneca’s $4.5 billion investment in Virginia expands its US drug manufacturing footprint, creating 3600 jobs and ...

Digitalization and automation enhance aseptic processing by improving speed, repeatability, and quality, with recipe-driven ...

US President Donald Trump was due to make an announcement that a source said would confirm AstraZeneca as the second of 17 major pharmaceutical companies, after Pfizer, to agree to most-favored-nation ...

Pharma accelerates specialized R&D and clinical pipelines via agentic AI and collaboration, while manufacturing scales through CGT 2.0 flexibility, automation, and digitized supply chain security.

AI/ML technologies are revolutionizing pharmaceutical formulation by optimizing excipient selection and predicting stability, reducing time and resources needed for development. Poor solubility of ...

The new label for prefilled syringes, in conjunction with innovations from SCHOTT Pharma, enables integrated tamper-evidence ...

At the Cell and Gene Meeting on the Mesa, a panel discussion was held on advanced therapy production and how it demands ...

The awarded $1.7 million in funding will support the company’s preclinical and clinical progress on DMX-1001 (noribogaine), ...

The licensing of Talicia, an FDA-approved fixed-dose therapy, to key at-risk markets strategically combats an increasingly ...

In this continuation of a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.

Siegfried Schmitt, PhD, vice-president, Technical at Parexel, answers questions on the use and benefits of real-world ...

This review of the nitrosamines contamination problem in pharmaceuticals takes a look at how the crisis started and developed ...